Carcinoid heart disease is a rare but serious cardiac condition that develops as a complication of carcinoid syndrome—a disorder caused by uncommon neuroendocrine tumors known as carcinoid tumors. Unlike typical heart diseases, this condition results from chemical substances released by tumors rather than direct tumor spread to the heart.

In carcinoid heart disease, fibrous, plaque-like material forms along the inner lining of the heart (endocardium), especially affecting the right-sided valves. This leads to malfunction of the valves, most commonly tricuspid regurgitation and pulmonary valve narrowing (stenosis), which can eventually progress to right-sided heart failure.

Because its symptoms often resemble more common heart conditions, diagnosis is frequently delayed, making awareness and early detection especially important.

 

How It Develops: From Tumor Activity to Heart Damage

The root cause of carcinoid heart disease lies in the hormones and chemicals secreted by carcinoid tumors—not the tumors themselves invading the heart.

1. Hormone Release from Tumors

Carcinoid tumors, typically found in the gastrointestinal tract (such as the small intestine or appendix) or lungs, produce high levels of biologically active substances. The most important of these is serotonin, along with other compounds like bradykinin and prostaglandins.

2. Escape into Circulation

Normally, these substances are broken down by the liver before they can affect the body. However, carcinoid heart disease develops when:

  • The tumor originates in the lungs (bypassing the liver), or
  • The cancer spreads to the liver, allowing hormones to enter the bloodstream directly

3. Formation of Fibrous Plaques

Continuous exposure to high levels of these chemicals damages the heart lining. This triggers abnormal tissue growth, leading to thick, fibrous deposits on heart valves. Over time, these deposits restrict valve movement and impair normal blood flow.

 

Connection to Carcinoid Syndrome

Carcinoid heart disease is considered the most severe complication of carcinoid syndrome. Along with heart involvement, patients may experience:

  • Flushing of the skin
  • Chronic diarrhea
  • Wheezing or breathing difficulty

Its presence significantly worsens overall prognosis, making early recognition critical.

 

Symptoms and Diagnosis

Common Symptoms

The signs often overlap with both carcinoid syndrome and right-sided heart failure, including:

  • Persistent fatigue
  • Shortness of breath, especially during activity
  • Swelling in the legs and ankles (edema)
  • Fluid buildup in the abdomen (ascites)

Doctors may also detect a heart murmur, typically due to tricuspid valve leakage.

 

Diagnostic Approach

A combination of imaging and laboratory tests is used to confirm the condition:

  • Echocardiogram (heart ultrasound):
  • This is the most important diagnostic tool. It shows thickened, stiff valves that do not move properly and evaluates the severity of valve damage.
  • Blood tests (NT-proBNP):
  • Elevated levels indicate strain on the right side of the heart.
  • 24-hour urine test (5-HIAA):
  • Measures a breakdown product of serotonin and helps confirm active carcinoid tumor activity.

 

Treatment: A Two-Part Strategy

Managing carcinoid heart disease requires treating both the tumor and the heart damage.

 

1. Controlling the Tumor

The goal is to reduce hormone production and slow disease progression:

  • Somatostatin analogs (e.g., octreotide, lanreotide):
  • These medications reduce hormone release and help control symptoms.
  • Liver-focused treatments:
  • Procedures like embolization or ablation are used when tumors have spread to the liver.
  • Advanced therapies:
  • Options such as peptide receptor radionuclide therapy (PRRT) or targeted medications may be used in more advanced cases.

 

2. Managing Heart Damage

  • Medications for heart failure:
  • Diuretics help reduce fluid buildup, though standard heart failure drugs are often less effective in this condition.
  • Valve replacement surgery:
  • This is the only definitive treatment for severe valve damage. Surgeons typically replace affected valves with tissue (bioprosthetic) valves. Timing is crucial—surgery should occur before permanent heart damage develops.
  • Preventing carcinoid crisis:
  • During surgery, patients are at risk of a dangerous hormone surge. This is managed with continuous medication (like octreotide) before and during the procedure.

 

Outlook and Importance of Specialized Care

In the past, carcinoid heart disease was associated with poor outcomes. However, advances in both cancer treatment and cardiac surgery have significantly improved survival rates.

Today, prognosis depends largely on how well the underlying tumor is controlled rather than the heart condition alone. This highlights the importance of care from a multidisciplinary team, including cardiologists, oncologists, and surgeons experienced in treating this rare disease.

 

Long-Term Management

Living with carcinoid heart disease requires ongoing care, including:

  • Regular echocardiograms to monitor heart function
  • Routine blood and urine tests
  • Strict adherence to prescribed treatments
  • Timely evaluation for surgery when needed

With proper management and coordinated care, many patients can achieve improved quality of life and better long-term outcomes despite this complex condition.